Literature DB >> 16621486

Release and diffusional modeling of metronidazole lipid matrices.

Mine Ozyazici1, Evren H Gökçe, Gökhan Ertan.   

Abstract

In this study, the first aim was to investigate the swelling and relaxation properties of lipid matrix on diffusional exponent (n). The second aim was to determine the desired release profile of metronidazole lipid matrix tablets. We prepared metronidazole lipid matrix granules using Carnauba wax, Beeswax, Stearic acid, Cutina HR, Precirol ATO 5, and Compritol ATO 888 by hot fusion method and pressed the tablets of these granules. In vitro release test was performed using a standard USP dissolution apparatus I (basket method) with a stirring rate of 100 rpm at 37 degrees C in 900 ml of 0.1 N hydrochloric acid, adjusted to pH 1.2, as medium for the formulations' screening. Hardness, diameter-height ratio, friability, and swelling ratio were determined. Target release profile of metronidazole was also drawn. Stearic acid showed the highest and Carnauba wax showed the lowest release rates in all formulations used. Swelling ratios were calculated after the dissolution of tablets as 9.24%, 6.03%, 1.74%, and 1.07% for Cutina HR, Beeswax, Precirol ATO 5, and Compritol ATO 888, respectively. There was erosion in Stearic acid, but neither erosion nor swelling in Carnauba wax, was detected. According to the power law analysis, the diffusion mechanism was expressed as pure Fickian for Stearic acid and Carnauba wax and the coupling of Fickian and relaxation contributions for other Cutina HR, Beeswax, Compritol ATO 888, and Precirol ATO 5 tablets. It was found that Beeswax (kd=2.13) has a very close drug release rate with the target profile (kt=1.95). Our results suggested that swelling and relaxation properties of lipid matrices should be examined together for a correct evaluation on drug diffusion mechanism of insoluble matrices.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621486     DOI: 10.1016/j.ejpb.2006.02.005

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  13 in total

1.  A design and evaluation of layered matrix tablet formulations of metoprolol tartrate.

Authors:  Esra Baloğlu; Taner Senyiğit
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

2.  Comparison between the effect of strongly and weakly cationic exchange resins on matrix physical properties and the controlled release of diphenhydramine hydrochloride from matrices.

Authors:  Prasert Akkaramongkolporn; Kaewnapa Wongsermsin; Praneet Opanasopit; Tanasait Ngawhirunpat
Journal:  AAPS PharmSciTech       Date:  2010-07-09       Impact factor: 3.246

3.  Chrono modulated multiple unit particulate systems (MUPS) via a continuous hot melt double extrusion technique: Investigation of the formulation and process suitability.

Authors:  Venkata Raman Kallakunta; Sandeep Sarabu; Narendar Dudhipala; Karthik Yadav Janga; Suresh Bandari; Feng Zhang; Michael A Repka
Journal:  Eur J Pharm Biopharm       Date:  2021-08-28       Impact factor: 5.571

4.  Wax-incorporated emulsion gel beads of calcium pectinate for intragastric floating drug delivery.

Authors:  Pornsak Sriamornsak; Panida Asavapichayont; Jurairat Nunthanid; Manee Luangtana-Anan; Sontaya Limmatvapirat; Suchada Piriyaprasarth
Journal:  AAPS PharmSciTech       Date:  2008-05-06       Impact factor: 3.246

5.  Effect of a pharmaceutical cationic exchange resin on the properties of controlled release diphenhydramine hydrochloride matrices using Methocel K4M or Ethocel 7cP as matrix formers.

Authors:  Prasert Akkaramongkolporn; Tanasait Ngawhirunpat; Jurairat Nunthanid; Praneet Opanasopit
Journal:  AAPS PharmSciTech       Date:  2008-07-31       Impact factor: 3.246

6.  Design and in vitro/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: relationship between swelling, erosion, and drug release.

Authors:  Soad A Yehia; Omaima N El-Gazayerly; Emad B Basalious
Journal:  AAPS PharmSciTech       Date:  2008-12-11       Impact factor: 3.246

7.  Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms.

Authors:  Marija Tubic-Grozdanis; John M Hilfinger; Gordon L Amidon; Jae Seung Kim; Paul Kijek; Petra Staubach; Peter Langguth
Journal:  Pharm Res       Date:  2008-01-24       Impact factor: 4.200

8.  Sucrose stearate-enriched lipid matrix tablets of etodolac: modulation of drug release, diffusional modeling and structure elucidation studies.

Authors:  Ahmed Abd-Elbary; Mina Ibrahim Tadros; Ahmed Adel Alaa-Eldin
Journal:  AAPS PharmSciTech       Date:  2013-04-10       Impact factor: 3.246

Review 9.  Solvent-free melting techniques for the preparation of lipid-based solid oral formulations.

Authors:  Karin Becker; Sharareh Salar-Behzadi; Andreas Zimmer
Journal:  Pharm Res       Date:  2015-03-19       Impact factor: 4.200

10.  Formulations Based on Drug Loaded Aptamer-Conjugated Liposomes as a Viable Strategy for the Topical Treatment of Basal Cell Carcinoma-In Vitro Tests.

Authors:  Anca N Cadinoiu; Delia M Rata; Leonard I Atanase; Cosmin T Mihai; Simona E Bacaita; Marcel Popa
Journal:  Pharmaceutics       Date:  2021-06-11       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.